Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
Plos Biology|November 24, 2016
Distribution of Misfolded Prion Protein Seeding Activity Alone Does Not Predict Regions of NeurodegenerationJames Alibhai, Richard A Blanco, Marcelo A Barria, et al.
The American Journal of Pathology|April 28, 2005
Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liverSandra J Campbell, V Hugh Perry, Fernando J Pitossi, et al.
Brain : a Journal of Neurology|February 6, 2018
A subarachnoid haemorrhage-specific outcome toolAdrian Pace, Sophie Mitchell, Elizabeth Casselden, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 24, 2003
CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injurySandra J Campbell, Paula M Hughes, John P Iredale, et al.
Journal of Neurology|July 25, 2024
Cerebrospinal fluid neurofilament light chain in acute optic neuritis and its predictive ability of multiple sclerosisMoschoula Passali, Ian Galea, Maria Højberg Knudsen, et al.
Blood Cells, Molecules & Diseases|August 16, 2024
Erythrocyte deformability correlates with systemic inflammationCarmen Jacob, Lakeesha Piyasundara, Maria Bonello, et al.
The Journal of Biological Chemistry|July 4, 2003
Characterization of the murine Nramp1 promoter: requirements for transactivation by Miz-1Holly Bowen, Abigail Lapham, Emma Phillips, et al.
The American Journal of Pathology|October 29, 2004
Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brainCarina C Ferrari, Amaicha M Depino, Federico Prada, et al.
International Journal of Molecular Sciences|July 13, 2024
Mild Systemic Inflammation Increases Erythrocyte FragilityCharlotte M Stuart, Carmen Jacob, Aravinthan Varatharaj, et al.
Annals of Neurology|April 1, 2018
Permeability of the blood-brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosisStig P Cramer, Helle J Simonsen, Aravinthan Varatharaj, et al.
Pageof 21